Home > Insider Trading > Filing (0001209191-14-035920)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1373707	Tetraphase Pharmaceuticals Inc	TTPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571997	Ph.d. R. Steven Gullans	480 Arsenal St, Suite 110 Watertown MA 02472		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-19	25,000	$9.24	25,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,468,505	Indirect	By Excel Medical Fund, L.P

Footnotes

The price reported represents the weighted average purchase price of shares purchased in multiple transactions at prices ranging from $9.05 to $9.36 per share. The reporting person undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Held by Excel Medical Fund, L.P. Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans is a Managing Director of Excel Medical Ventures, LLC. Mr. Gullans may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Mr. Gullans disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.